Approach to haemangiomatosis causing congestive heart failure.

Roie Tal, Moshe Dotan, Avraham Lorber

Journal: Acta paediatrica (Oslo, Norway : 1992) 2017;105(6):600-4

PMID: 26859502

Abstract

UNLABELLED

Haemangiomas represent the most common tumour of infancy. Although most cases are cutaneous benign lesions, multiple skin haemangiomas are associated with visceral involvement, especially of the liver. Hepatic haemangiomatosis may be complicated by high-output cardiac failure due to high-flow arteriovenous connections within the lesions. Different therapeutic strategies for treating haemangiomatosis causing heart failure include medical, surgical and interventional modalities. This study aimed to review the treatment options, discuss their benefits and flaws and propose a practical therapeutic approach for this medical situation.

CONCLUSION

Our approach incorporates heart failure medications, dietary support and propranolol as first-line treatment, while corticosteroids, vincristine, percutaneous intervention and surgery are reserved for refractory cases.

©2016 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Address: Pediatric Cardiology and Adults with Congenital Heart Disease, Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.; Pediatric Cardiology, Ziv Medical Center, Safed, Israel.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.